123 related articles for article (PubMed ID: 27873267)
1. Generation and Infection of Organotypic Cultures with Epstein-Barr Virus.
Temple RM; Meyers C; Sample CE
Methods Mol Biol; 2017; 1532():65-78. PubMed ID: 27873267
[TBL] [Abstract][Full Text] [Related]
2. Efficient replication of Epstein-Barr virus in stratified epithelium in vitro.
Temple RM; Zhu J; Budgeon L; Christensen ND; Meyers C; Sample CE
Proc Natl Acad Sci U S A; 2014 Nov; 111(46):16544-9. PubMed ID: 25313069
[TBL] [Abstract][Full Text] [Related]
3. The Epstein-Barr Virus Glycoprotein BDLF2 Is Essential for Efficient Viral Spread in Stratified Epithelium.
Walston JJ; Hayman IR; Gore M; Ferguson M; Temple RM; Liao J; Alam S; Meyers C; Tugizov SM; Hutt-Fletcher L; Sample CE
J Virol; 2023 Feb; 97(2):e0152822. PubMed ID: 36688650
[TBL] [Abstract][Full Text] [Related]
4. Epstein-Barr Virus Infection Promotes Epithelial Cell Growth by Attenuating Differentiation-Dependent Exit from the Cell Cycle.
Eichelberg MR; Welch R; Guidry JT; Ali A; Ohashi M; Makielski KR; McChesney K; Van Sciver N; Lambert PF; Keleș S; Kenney SC; Scott RS; Johannsen E
mBio; 2019 Aug; 10(4):. PubMed ID: 31431547
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of Epstein-Barr Virus Replication in Human Papillomavirus-Immortalized Keratinocytes.
Guidry JT; Myers JE; Bienkowska-Haba M; Songock WK; Ma X; Shi M; Nathan CO; Bodily JM; Sapp MJ; Scott RS
J Virol; 2019 Jan; 93(2):. PubMed ID: 30381489
[TBL] [Abstract][Full Text] [Related]
6. Human papillomavirus promotes Epstein-Barr virus maintenance and lytic reactivation in immortalized oral keratinocytes.
Makielski KR; Lee D; Lorenz LD; Nawandar DM; Chiu YF; Kenney SC; Lambert PF
Virology; 2016 Aug; 495():52-62. PubMed ID: 27179345
[TBL] [Abstract][Full Text] [Related]
7. Secreted Oral Epithelial Cell Membrane Vesicles Induce Epstein-Barr Virus Reactivation in Latently Infected B Cells.
Lin Z; Swan K; Zhang X; Cao S; Brett Z; Drury S; Strong MJ; Fewell C; Puetter A; Wang X; Ferris M; Sullivan DE; Li L; Flemington EK
J Virol; 2016 Jan; 90(7):3469-79. PubMed ID: 26764001
[TBL] [Abstract][Full Text] [Related]
8. Air-Liquid Interface Method To Study Epstein-Barr Virus Pathogenesis in Nasopharyngeal Epithelial Cells.
Caves EA; Cook SA; Lee N; Stoltz D; Watkins S; Shair KHY
mSphere; 2018 Jul; 3(4):. PubMed ID: 30021875
[TBL] [Abstract][Full Text] [Related]
9. Retinoblastoma Protein Is Required for Epstein-Barr Virus Replication in Differentiated Epithelia.
Myers JE; Schaal DL; Nkadi EH; Ward BJH; Bienkowska-Haba M; Sapp M; Bodily JM; Scott RS
J Virol; 2023 Feb; 97(2):e0103222. PubMed ID: 36719239
[TBL] [Abstract][Full Text] [Related]
10. New insight into Epstein-Barr virus infection using models of stratified epithelium.
Hayman IR; Temple RM; Burgess CK; Ferguson M; Liao J; Meyers C; Sample CE
PLoS Pathog; 2023 Jan; 19(1):e1011040. PubMed ID: 36630458
[TBL] [Abstract][Full Text] [Related]
11. Epstein-Barr virus infection of Langerhans cell precursors as a mechanism of oral epithelial entry, persistence, and reactivation.
Walling DM; Ray AJ; Nichols JE; Flaitz CM; Nichols CM
J Virol; 2007 Jul; 81(13):7249-68. PubMed ID: 17376908
[TBL] [Abstract][Full Text] [Related]
12. Persistent productive Epstein-Barr virus replication in normal epithelial cells in vivo.
Walling DM; Flaitz CM; Nichols CM; Hudnall SD; Adler-Storthz K
J Infect Dis; 2001 Dec; 184(12):1499-507. PubMed ID: 11740724
[TBL] [Abstract][Full Text] [Related]
13. Features distinguishing Epstein-Barr virus infections of epithelial cells and B cells: viral genome expression, genome maintenance, and genome amplification.
Shannon-Lowe C; Adland E; Bell AI; Delecluse HJ; Rickinson AB; Rowe M
J Virol; 2009 Aug; 83(15):7749-60. PubMed ID: 19439479
[TBL] [Abstract][Full Text] [Related]
14. Epstein-Barr virus infection in oral hairy leukoplakia: virus replication in the absence of a detectable latent phase.
Niedobitek G; Young LS; Lau R; Brooks L; Greenspan D; Greenspan JS; Rickinson AB
J Gen Virol; 1991 Dec; 72 ( Pt 12)():3035-46. PubMed ID: 1662695
[TBL] [Abstract][Full Text] [Related]
15. Cellular differentiation regulator BLIMP1 induces Epstein-Barr virus lytic reactivation in epithelial and B cells by activating transcription from both the R and Z promoters.
Reusch JA; Nawandar DM; Wright KL; Kenney SC; Mertz JE
J Virol; 2015 Feb; 89(3):1731-43. PubMed ID: 25410866
[TBL] [Abstract][Full Text] [Related]
16. Epstein-Barr virus (EBV)-infected monocytes facilitate dissemination of EBV within the oral mucosal epithelium.
Tugizov S; Herrera R; Veluppillai P; Greenspan J; Greenspan D; Palefsky JM
J Virol; 2007 Jun; 81(11):5484-96. PubMed ID: 17376918
[TBL] [Abstract][Full Text] [Related]
17. Regulation and dysregulation of Epstein-Barr virus latency: implications for the development of autoimmune diseases.
Niller HH; Wolf H; Minarovits J
Autoimmunity; 2008 May; 41(4):298-328. PubMed ID: 18432410
[TBL] [Abstract][Full Text] [Related]
18. Analysis of Epstein-Barr virus infection models in a series of pediatric carriers from a developing country.
Vistarop AG; Cohen M; De Matteo E; Preciado MV; Chabay PA
Sci Rep; 2016 Mar; 6():23303. PubMed ID: 26988293
[TBL] [Abstract][Full Text] [Related]
19. Latent and lytic Epstein-Barr virus replication strategies.
Tsurumi T; Fujita M; Kudoh A
Rev Med Virol; 2005; 15(1):3-15. PubMed ID: 15386591
[TBL] [Abstract][Full Text] [Related]
20. Niclosamide inhibits lytic replication of Epstein-Barr virus by disrupting mTOR activation.
Huang L; Yang M; Yuan Y; Li X; Kuang E
Antiviral Res; 2017 Feb; 138():68-78. PubMed ID: 27939840
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
